Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Hopper

Showing results (381-390 of 894) with videos related to

Pageof 90
Sort By:
Journal of Medical Genetics|April 24, 2010
A BRCA1 promoter variant (rs11655505) and breast cancer riskPaolo Verderio, Sara Pizzamiglio, Melissa C Southey, et al.
Plos One|June 21, 2013
PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survivalChristophe Rosty, Joanne P Young, Michael D Walsh, et al.
Cancer Epidemiology|May 16, 2025
Allergic disease and risk of multiple myeloma: A case-control studySimon Cheah, Adrian J Lowe, Nina Afshar, et al.
International Journal of Cancer|February 17, 2019
Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosisHarindra Jayasekara, Robert J MacInnis, James A Chamberlain, et al.
Transfusion|October 12, 2011
A comparison of self-reported and record-linked blood donation history in an Australian cohortNadine A Bertalli, Katrina J Allen, Christine E McLaren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer riskBettina Kuschel, Georgia Chenevix-Trench, Amanda B Spurdle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutationsRoger L Milne, Julia A Knight, Esther M John, et al.
Scientific Reports|October 17, 2018
BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impactsJoo-Yeon Lee, Jisun Kim, Sung-Won Kim, et al.
Journal of Gastroenterology and Hepatology|October 15, 2014
Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year studySophie G Zaloumis, Katrina J Allen, Nadine A Bertalli, et al.
JAMA Dermatology|June 9, 2016
Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk FactorsKylie Vuong, Bruce K Armstrong, Elisabete Weiderpass, et al.
Pageof 90

Showing results (381-390 of 894) with videos related to

Sort By:
Pageof 90
Journal of Medical Genetics|April 24, 2010
A BRCA1 promoter variant (rs11655505) and breast cancer riskPaolo Verderio, Sara Pizzamiglio, Melissa C Southey, et al.
Plos One|June 21, 2013
PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survivalChristophe Rosty, Joanne P Young, Michael D Walsh, et al.
Cancer Epidemiology|May 16, 2025
Allergic disease and risk of multiple myeloma: A case-control studySimon Cheah, Adrian J Lowe, Nina Afshar, et al.
International Journal of Cancer|February 17, 2019
Mortality after breast cancer as a function of time since diagnosis by estrogen receptor status and age at diagnosisHarindra Jayasekara, Robert J MacInnis, James A Chamberlain, et al.
Transfusion|October 12, 2011
A comparison of self-reported and record-linked blood donation history in an Australian cohortNadine A Bertalli, Katrina J Allen, Christine E McLaren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer riskBettina Kuschel, Georgia Chenevix-Trench, Amanda B Spurdle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 2005
Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutationsRoger L Milne, Julia A Knight, Esther M John, et al.
Scientific Reports|October 17, 2018
BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impactsJoo-Yeon Lee, Jisun Kim, Sung-Won Kim, et al.
Journal of Gastroenterology and Hepatology|October 15, 2014
Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year studySophie G Zaloumis, Katrina J Allen, Nadine A Bertalli, et al.
JAMA Dermatology|June 9, 2016
Development and External Validation of a Melanoma Risk Prediction Model Based on Self-assessed Risk FactorsKylie Vuong, Bruce K Armstrong, Elisabete Weiderpass, et al.
Pageof 90